关于我们 - About Us - Beijing PrimeGene Science and Technology Co., Ltd.

CFO & CMO (Founder, director)

Du Yunlong

• Be responsible for corporate strategy formulation, overall operation and clinical management
• Led the research and development of several projects, and NDA preparation and submission at Hua Medicine, and contributed to the company getting listed in Hong Kong in 2018
• Having worked at well-known multinational corporations such as Pfizer and GSK over 20 years, and with rich whole-process experience covering early research and development, clinical development and product launching
• Took charge of Phase I to IV clinical trials, medical affairs and drug safety management in the areas of dermatology, metabolism and neurology, and participated in the preparation and submission of several NDAs
• PhD of Albany Medical College, and bachelor of medicine of Peking University; US medical license
• Own 15 invention patents, and have published over 20 articles

President (Founder)

Li Yuliang

• Be responsible for corporate development strategy
• With more than 20 years of industrial operation management and investment experience, foresight of deeply planning pharmaceutical industry, entrepreneurial and initiative spirits, and strong resource integration capability
• Founded Chifeng Saliont pharmaceutical Co., Ltd. and Beijing PrimeGene Science and Technology Co., Ltd. successively in 2012
• Was awarded with “Outstanding Individual of Entrepreneurship” of the Nei Monggol Autonomous Region

Chief Financial Officer (CFO)

Li Hua

• Be responsible for corporate financial management, financial strategy and capital management
• With rich experience of financing, capital operation, and group financial system planning, construction and operation, and led the whole process of preparing for A-share and NEEQ listing for several renowned companies
• Having worked at Fosun Pharmaceutical, ZENJIPHARMA, Wanfeng Aowei and other renowned transnational enterprises and private listed enterprises about 20 years

Chief Technology Officer (CTO)

Kang Lisheng

• 负责公司CMC中心和制剂研究中心的工作,指导外用制剂研发平台的建立
• 20多年国外跨国药企新产品开发及CMC团队管理工作经验，国内药企CMC研发/生产体系领导管理经验。半固体、固体及注射剂等多种剂型的开发经验，包括特殊制剂，如复杂乳膏，纳米乳剂，纳米混悬剂，口服控释制剂等。曾担任跨国药企原料药固体形态策略委员会主任
• 曾在Celgene、GSK、Pfizer、 Eli Lilly等跨国药企美国研发中心负责I-III期临床阶段及商业化阶段新产品的制剂及CMC跨领域开发，曾直接参与或领导多个成功产品的药学开发工作
• 美国佐治亚大学药剂学博士，北京大学药学学士

Early Research Vice President

Zhu Bing

• Be responsible for early research and development of the company
• With over 25 years of international drug research and development experience
• Worked at Zelgen, Crown Bioscience, drug R&D center of Michl Institute of the University of Alabama System, and so on.
• With rich and solid hands-on experience of identifying and verifying new drug targets, designing, screening and optimizing novel compounds, and further validation of leading compounds and preclinical candidates thereof. Have published over 20 academic papers.
• Doctor of pharmacology of Beijing Union Medical College

Assistant President

Sun Yue

• Be responsible for operation of the company’s clinical research and development center.
• Took charge of medical affairs at Global 500 pharmaceutical enterprises for more than 15 years, including Novartis Pharma, Novo Nordisk, GSK, etc.
• With rich and solid hands-on experience of clinical study, medical strategy making and implementation, medical governance, clinical trial PV system construction, MSL performance tracking and evaluation, medical capacity building and training, medical information service, digital clinical trial platform construction, competitive product information monitoring and strategic response analysis.
• Doctor of clinical traditional Chinese pharmacology of Beijing University of Chinese Medicine

Board Secretary & Vice President of Administration Center

Wu Xing

• Be responsible for administrative affairs of board office, market, and personnel management
• With rich experience of financial investment and business administration
• Having worked at large state-owned financial institutions for more than 10 years, such as Bank of Communications
• Master of finance of Shanxi University of Finance and Economics

Quality Vice President

Ye Dong

• Be responsible for the company’s quality assurance and commercial production management
• With rich experience of drug research and development, production management, quality control, technical management, industrialization and technology transfer, and pharmaceutical factory project planning and construction
• Having engaged in pharmaceutical industry for over 20 years, and worked at ZBD Pharmaceutical, Fujian Cosunter Pharmaceutical, and AOSAIKANG PHARM
• Master of pharmaceutical engineering of Nanjing Tech University